Secondary coronary heart disease prevention by red wine?
Assmann, G.
Der Internist 40(9): 982
1999
ISSN/ISBN: 0020-9554 PMID: 10577009 Document Number: 498241
Document emailed within 1 workday
Related Documents
Wilhelmsen, L. 1982: Secondary prevention of coronary heart disease. A review Cor et Vasa 24(4): 216-227Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Meinertz, T.; Heitzer, T. 2002: Primary and secondary prevention of coronary heart disease: smoking Zeitschrift für Kardiologie 91 Suppl. 2: 3-11
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Lindbloom, E.J.; Eaton, L.J. 2002: Cost effectiveness of aspirin vs clopidogrel for secondary prevention of coronary heart disease Journal of Family Practice 51(9): 789
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
Arnheim, K. 2000: Coronary heart disease: grave deficiencies in secondary prevention. Almost no one is concerned with blood lipids MMW Fortschritte der Medizin 142(24): 18
McKenna, C.J.; Sugrue, D.D. 1995: Secondary prevention in coronary heart disease. Fact: lowering cholesterol saves lives Irish Medical Journal 88(6): 191
Jost, S.; Lichtlen, P.R. 1995: Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease Zeitschrift für Kardiologie 84(8): 577-595
Enbergs, A.; Liese, A.; Heimbach, M.; Kerber, S.; Scheld, H.H.; Breithardt, G.; Kleine-Katthöfer, P.; Keil, U. 1997: Evaluation of secondary prevention of coronary heart disease. Results of the EUROSPIRE study in the Munster region Zeitschrift für Kardiologie 86(4): 284-291
Pokrovskaia, E.V. 2004: Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES Kardiologiia 44(10): 82-83
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Novák, J. 1988: The program for primary prevention and secondary prevention of ischemic coronary disease and research at the Laboratory of Human Energy Resources of the University of Wyoming in Laramie Casopis Lekaru Ceskych 127(37-38): 1190-1192
Haghfelt, T.H. 1999: Secondary prevention of patients with documented ischemic heart disease Ugeskrift for Laeger 161(24): 3630
2007: Intervention with clarithromycin in patients with stable coronary heart disease--the CLARICOR trial: secondary publication Ugeskrift for Laeger 169(6): 497-499
Samani, N.J.; de Bono, D.P. 1996: Prevention of coronary heart disease with pravastatin New England Journal of Medicine 334(20): 1333-1334; Author Reply 1334-1335
Singh, R.B.; Niaz, M.A. 1994: Prevention of coronary heart disease in Indians Journal of the Association of Physicians of India 42(7): 545-548
Hloucal, L.; Dusek, J. 1972: Etiopathogenesis and prevention of coronary heart disease Acta Universitatis Carolinae. Medica 18(5-6): 203-227
Butler, R.M.; Goldberg, L. 1989: Exercise and prevention of coronary heart disease Primary Care 16(1): 99-114
Scott, R.S.; Lintott, C.J.; Bremer, J.; Nye, E.R. 1987: Hyperlipidaemia and the prevention of coronary heart disease New Zealand Medical Journal 100(836): 717-719